GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...

This resulted in seven deaths and multiple injuries to various people, again, because of the inaccuracy in a specific set of ...

Our paper provides an overview of the code, features, and examples for the first released version of the application (1.0.11.0). For newer versions, please refer to the examples in the viewer ...

Abbott's (NYSE: ABT) newest sensor-based glucose technology, the FreeStyle Libre 3 Plus* sensor, is now publicly funded in ...

Click on Layers and choose "Add a layer", and "Provide a layer version ARN" and enter the following ARN. If you don't use aws-lambda-libreoffice npm package, then these steps are roughly what you need ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

Abbott has launched Libre Assist, a feature within the Libre app designed to help people living with diabetes better understand how the foods they eat affect their glucose levels.

Libre Assist 1 uses generative AI to predict how a food choice may affect a person's glucose levels. 2 It then offers ...

Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s ...

Now Core Devices is ready for Round 2. Literally. The Pebble Round 2 is available for pre-order today for $199, and it’s expected to begin shipping to customers in May, 2026.

Insulet PODD is well-poised to grow in the coming quarters due to the strength of its Omnipod 5 platform. The company is strongly executing against its long-term priorities to drive penetration, ...

As the year comes to a close, it's time to look back at the numerous innovations across the diabetes technology industry in ...